FCA Venture Partners
VC Fund
Brentwood, United States
FCA Venture Partners is a VC fund in Brentwood focused on Health Care and Software. Founded in 1996, FCA Venture Partners has a long history of investing in successful healthcare entrepreneurs. The firm is passionate about building sustainable businesses and providing strategic value to their portfolio companies. FCA invests $3-6M in fast growing healthcare companies making processes in the industry faster, better, and cheaperwhile improving the quality of care and the patient experience. With its location in Nashville, roots with Clayton Associates and the McWhorter Family, and deep involvement in the growth of the U.S. healthcare community, FCA Venture Partners is poised to take advantage of disruptive opportunities that help move healthcare forward.
- Total investments:
- 92
- Last investment:
- Lead investor:
- 40%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries FCA Venture Partners invests in
Stages FCA Venture Partners invests in
Countries FCA Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $3M–$17M
- Series B
- $3M–$27M
Investment Focus
Industry
- Health Care 43 (47%)
- Software 19 (21%)
- Medical 14 (15%)
- Information Technology 9 (10%)
- Medical Device 8 (9%)
Stage
- Series A 31 (34%)
- Series B 14 (15%)
- Funding Round 14 (15%)
- Seed 7 (8%)
- Convertible Note 5 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andrew Bouldin
Partner
|
Partner | Total investments: 3 | Find email | |
|
George Curran
Associate
|
Associate | Total investments: 0 | Find email | |
|
John R. Burch
Managing Partner
|
Managing Partner | Total investments: 7 | Find email | |
|
Matthew King
Managing Partner
|
Managing Partner | Total investments: 22 | Find email | |
|
Nancy S. Allen
Partner & CFO
|
Partner & CFO | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Billions of dollars of prescription medications are wasted each year due to expiring inventory, overstock issues and the like. And, all too often patients can’t find the medications they need, even when the drug might be at another pharmacy close by.InStockRx solves this problem. We provide: a self-populating marketplace where pharmacies canbuy and sell with each other, a robust inventory analytics SaaS tool that pinpoints inventory issues and an in-stock drug search engine so pharmacies can easily find the drugs they need on the marketplace. Pharmacies buy and sell with each other today, but just don't have the right tools. With InStockRx, they do. | $5M / Series A / Jul 01, 2026 | |
|
|
BranchLab makes healthcare advertising better so that people may find the best healthcare options. | $28.8M / Series A / May 13, 2026 | |
|
|
Coral Care is a technology company for in-person specialized pediatric developmental healthcare. It aims to improve access to pediatric developmental health services from infancy to adolescence. The platform serves as a marketplace, offering a simplified path to care by matching families with Coral Care’s team of trusted, local, in-networkpediatric specialists available for in-person and in-home sessions.Coral Care’s platform provides pediatric specialists with the infrastructure needed to grow their private practices and deliver quality in-person care. The company offers administrative support and tools, content, credentialing services, and marketing services, which enable pediatric specialists to focus on care, not managing their businesses. | $13M / Series A / Feb 23, 2026 | |
|
|
Primum is a digital platform that connects general oncologists to subspecialist oncologists for help on their most complex cases. | Seed / Sep 25, 2025 | |
|
|
Our healthcare system assumes we make decisions based on what is best for us. But it’s not that simple. Everyday stressors often cloud our judgement as to what’s best in the long run. For people with chronic conditions, this can make healthy habit formation difficult. Wellth is a venture-backed digital health company that improves adherence inchronic disease populations. Using the science of behavioral economics—combined with an appreciation for human nature—we uncover and address the unique obstacles that prevent people with chronic conditions from improving patient outcomes. Our program goes beyond current efforts to boost adherence with technology, reminders, and coaching solutions using contingency management and loss aversion to create motivation, behavior change and improve population health at scale.In addition to our RCT-proven outcomes, our easy-to-use mobile platform experience has been proven by health plans, providers, and other organizations to empower members with the incentives and support system they need to establish new healthy habits. Key outcomes for members include improved med and care plan adherence, reduction in readmissions, hospitalizations, and ED utilization, improved PDC, and more. Learn more at www.wellthapp.com. | $36M / Series C / Aug 20, 2025 | |
|
|
Ignite is the UK’s leading provider of technology-driven Patient Recruitment and Real-World Evidence solutions. | $10.9M / Series A / Aug 14, 2025 | |
|
|
EvolvedMD is leading the integration of behavioral health services in modern primary care. | $34M / Series B / Jul 14, 2025 | |
|
|
Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients. | Series A / Jun 26, 2025 | |
|
|
Posterity Health educate, engage, and encourage couples to approach the conception process together as an integrated unit. Posterity Health is the only digital male fertility platform that empowers men to learn about their partner's fertility and take action. | $17M / Series A / Feb 18, 2025 | |
|
|
Posterity Health educate, engage, and encourage couples to approach the conception process together as an integrated unit. Posterity Health is the only digital male fertility platform that empowers men to learn about their partner's fertility and take action. | $17M / Series A / Feb 18, 2025 | |
| See all 92 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does FCA Venture Partners invest in?
FCA Venture Partners invests primarily in Health Care, Software and Medical startups, most often at Series A and Series B stage. Most of the 92 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is FCA Venture Partners's check size?
FCA Venture Partners typically joins rounds of $3M–$17M at Series A and $3M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds FCA Venture Partners participates in.
How do I contact FCA Venture Partners?
Public channels for FCA Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at FCA Venture Partners?
The team at FCA Venture Partners includes Andrew Bouldin (Partner), George Curran (Associate) and John R. Burch (Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!